← Open Payments lookup

AMANDA ZUBER: Open Payments

NPI 1215493747 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$393 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $420 · 2025 $393

Food & beverage: $393
CompanyPaymentsAmount
GlaxoSmithKline, LLC.4$96
Octapharma USA, Inc.1$42
Lundbeck LLC2$41
AstraZeneca Pharmaceuticals LP1$33
Janssen Biotech, Inc.1$33
Genentech USA, Inc.1$31
TG Therapeutics, Inc.1$31
SOBI, INC1$31
PFIZER INC.1$29
Alexion Pharmaceuticals, Inc.1$25

Products named: NUCALA, OCTAGAM IMMUNE GLOBULIN (HUMAN), VYEPTI, SAPHNELO, TREMFYA, Ocrevus Zunovo, BRIUMVI, ULTOMIRIS.

Industry payments across CO — which companies pay providers there.